IL1B and gout: In a mouse gouty arthritis model, oral administration of CAPE inhibited MSU crystal-induced caspase-1 activation and IL-1β production in air pouch exudate and foot tissue thus attenuating inflammatory symptoms (Lee et al. 2016).